title: Impact of etiology of secondary ureteropelvic junction obstruction on outcome of endopyelotomy.
abstract: Endopyelotomy for secondary ureteropelvic junction obstruction (UPJO) is a highly effective procedure. However, the impact of the etiology of the obstruction on the outcome of an endopyelotomy has not been defined. Herein, we review the success rates with endopyelotomy for secondary UPJO after failure of open pyeloplasty or endopyelotomy. Thirty-five adult patients with both objective and subjective follow-up were identified retrospectively who had endopyelotomy for secondary UPJO. Twenty-four patients had failed a previous open reconstruction (23) or laparoscopic Foley Y-V plasty (1). Eleven patients had failed a prior endopyelotomy. Retrograde endopyelotomy was performed using the Acucise device in 11 patients, and antegrade endopyelotomy was performed in 24 patients. Objective follow-up was obtained with diuretic renal scintigraphy (mean 14.1 months) and subjective follow-up by analog pain scales (mean 27.8 months). Objective success was defined as no obstruction on renal scintigraphy, while subjective success was used to describe a minimum of 50% resolution of symptoms. The subjective success rate of secondary endopyelotomy in the open-pyeloplasty group was 88% v 71% in the prior endopyelotomy group (P = 0.20). The objective success rate in the failed-pyeloplasty group was 71% v 55% in the prior endopyelotomy group (P = 0.40). Endopyelotomy for secondary UPJO has a good success rate. Success rates tend to be higher in patients who have failed an open pyeloplasty; however, a statistically significant difference was not seen between the two groups.
authors.affiliation: Division of Urology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Hoenig
authors.forename: A L
authors.initials: AL
authors.lastname: Shalhav
authors.forename: A M
authors.initials: AM
authors.lastname: Elbahnasy
authors.forename: E M
authors.initials: EM
authors.lastname: McDougall
authors.forename: D
authors.initials: D
authors.lastname: Smith
authors.forename: R V
authors.initials: RV
authors.lastname: Clayman
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004724:Endoscopy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000000981:diagnostic imaging; D007682:Kidney Pelvis / Q000601:surgery*; D008875:Middle Aged; D009403:Nephrostomy, Percutaneous; D010149:Postoperative Pain / Q000503:physiopathology; D011877:Radionuclide Imaging; D019233:Retreatment; D012189:Retrospective Studies; D015607:Stents; D016896:Treatment Outcome; D014221:Triamcinolone / Q000627:therapeutic use; D014517:Ureteral Obstruction / Q000209:etiology* / Q000601:surgery*
chemical_list: D005938:Glucocorticoids; D014221:Triamcinolone